A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product

Recruiting now

Conditions studied: Hematological Malignancy, Solid Tumor Malignancy

In brief

This study is designed to collect long-term safety and survival data from participants previously treated in an eligible Century-sponsored index trial. This is an observational study, and the elements of the study design allow for important follow-up for safety, survival, and the continued evaluation of any late adverse events (AEs) that may appear after treatment with such cellular products. Additionally, collection of persistence data from participants will support the identification of any long-term risks or late AEs that may be causally related to treatment with such cellular products.

Key facts

Study ID
NCT05768269
Run by
Century Therapeutics, Inc.
People needed
375
Starts
2024-04-29
Expected to finish
2040-03-01
Last updated by the study team
2025-06-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.